Author

B. A. Carneiro

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:flow cytometry· 1 Assay:proteomics· 1

Frequent Co-Authors

K. E. Huntington· 3 shared L. Zhou· 3 shared W. S. El-Deiry· 3 shared A. A. Seyhan· 1 shared A. D. Louie· 1 shared A. De Souza· 1 shared A. George· 1 shared B. Borden· 1 shared

Activity by Year

2023-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

K. E. Huntington

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

TRAIL pathway suppression of cancer cell growth and immune cell-mediated tumor cell-killing in a senescent fibroblast-constructed tumor microenvironment

S. Zhang, K. E. Huntington, L. Zhou, A. A. Seyhan, B. Kun, B. A. Carneiro, J. Kreiling, J. M. Sedivy, W. S. El-Deiry

This study investigates how senescent fibroblasts influence tumor growth and immune response, showing that targeting the p21-driven SASP and combining senolytics with cancer therapies can suppress tumor growth.

bioRxiv · Nov 30, 2023 · PreprintCancer Biology

Androgen receptor signaling blockade enhances NK cell-mediated killing of prostate cancer cells and sensitivity to NK cell checkpoint blockade

M. Pinho-Schwermann, C. Purcell, L. Carlsen, K. E. Huntington, P. R. Srinivasan, A. George, V. Tajiknia, W. MacDonald, L. Zhou, L. Zhang, A. De Souza, H. P. Safran, B. A. Carneiro, W. S. El-Deiry

This study shows that androgen receptor inhibitors enhance NK cell-mediated killing of prostate cancer cells and sensitivity to NKG2A checkpoint blockade by upregulating HLA-E expression.

bioRxiv · Nov 15, 2023 · PreprintCancer Biology

GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer

K. E. Huntington, A. D. Louie, P. Srinivasan, C. Schorl, S. Lu, D. Silverberg, D. Newhouse, Z. Wu, L. Zhou, B. Borden, F. J. Giles, M. Dooner, B. A. Carneiro, W. S. El-Deiry

This study shows that elraglusib enhances immune cell activation and synergizes with anti-PD-L1 in a murine colorectal cancer model, with clinical implications for combination immunotherapy.

bioRxiv · Feb 7, 2023Cancer Biology